| Product Name | MF | CAS | Details |
|---|
| SNU-739 | Details |
| TALEN technology | Details |
| Tumor model | Details |
| Whole genome resequencing | Details |
| Gene therapy | Details |
| Co-immunoprecipitation (CO-IP) | Details |
| Promoter, enhancer sequence capture | Details |
| Transcriptome sequencing | Details |
| TUNEL staining | Details |
| Dual luciferase verification of binding sites of MIRNA to target gene | Details |
| Immunohistochemistry | Details |
| Promoter, enhancer reporter gene vector construction | Details |
| Stable cell strain screening | Details |
| Immunofluorescence | Details |
| HE staining | Details |
| Immunohistochemistry | Details |
| BEL-7404 | Details |
| BGC-823 | Details |
| COLO 205 | Details |
| Eca-109 | Details |
| HCAEC | Details |
| Hep3B | Details |
| LoVo | Details |
| MKN-45 | Details |
| 3`UTR sequence fishing | Details |
| NA | Details |
| CART cell immunotherapy | Details |
| MIRNA Gene Fishing | Details |
| PDX model | Details |
| RNAI vector construction | Details |
| NA | Details |
| Clinical Grade Lentivirus | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| NA | Details |
| HaCaT | Details |
| HUVEC[HUV-EC-C] | Details |
| T24 | Details |
| NA | Details |
| 293 | Details |
| 293T | Details |
| 5637 | Details |
| 786-O | Details |
| B16-F0 | Details |
| BEL-7402 | Details |
| BT-474 | Details |
| BxPC-3 | Details |
| CAL 27 | Details |
| Cho-K1 | Details |
| CNE | Details |
| GBC-SD | Details |
| GES-1 | Details |
| Hepa1-6 | Details |
| HGC-27 | Details |
| LLC-PK1 | Details |
| NCI-H460 | Details |
| RSC96 | Details |
| RWPE-1 | Details |
| SGC-7901 | Details |
| TE-1 | Details |
| U251 | Details |
| MIRNA sequencing | Details |
| Site-directed mutation | Details |
| Scratch test | Details |
| Cloning formation experiment | Details |
| Exome sequencing | Details |
| 293FT | Details |
| L929 | Details |
| NUGC-3 | Details |
| PK（15） | Details |
| SNU-638 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||